V. Breese

Heterogeneity of colorectal cancer (CRC) in reference to KRAS proto-oncogene utilizing WAVE technology.

P. Quesenberry, D. Chatterjee, C. Jackson, 2013, Experimental and molecular pathology.

KRAS Mutations in Mucinous Lesions of the Uterus.

C. Jackson, Jinjun Xiong, M. Steinhoff, 2015, American journal of clinical pathology.

Analytical Validation of a Hybrid Capture–Based Next-Generation Sequencing Clinical Assay for Genomic Profiling of Cell-Free Circulating Tumor DNA

Doron Lipson, Bernard Fendler, Jeffrey P. Gregg, 2018, The Journal of molecular diagnostics : JMD.

The clinical significance of K-ras mutation in endometrial "surface epithelial changes" and their associated endometrial adenocarcinoma.

C. Sung, C. Jackson, Jinjun Xiong, 2016, Gynecologic oncology.

BRAF V600E Mutations in Endometrial Adenocarcinoma

Jinjun Xiong, Steven Hang, C. Jackson, 2013, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

Circulating Tumor DNA and Biomarker Analyses From the LOTUS Randomized Trial of First-Line Ipatasertib and Paclitaxel for Metastatic Triple-Negative Breast Cancer.

Sung-Bae Kim, D. Lipson, M. Wongchenko, 2020, JCO precision oncology.

Application of BRAF V600E mutation analysis for the diagnosis of metanephric adenofibroma.

C. Jackson, S. Mangray, E. Yakirevich, 2015, The American journal of surgical pathology.

Analytic validation of a clinical circulating tumor DNA assay for patients with solid tumors

T. Clark, D. Lipson, V. Miller, 2016 .

Abstract 3965: Rigorous validation of a clinical circulating tumor DNA assay for cancer molecular profiling

T. Clark, D. Lipson, G. Otto, 2016 .